- Human pathology

Home > A. Molecular pathology > SOX17


Tuesday 5 January 2010


- SOX17 promoter methylation in cell free DNA of patients with operable gastric cancer is a frequent event and may provide important information regarding prognosis in this group of patients. PMID: 23403728


- Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival. Balgkouranidou I, Karayiannakis A, Matthaios D, Bolanaki H, Tripsianis G, Tentes AA, Lianidou E, Chatzaki E, Fiska A, Lambropoulou M, Kolios G, Kakolyris S. Clin Chem Lab Med. 2013 Feb 13:1-6. doi : 10.1515/cclm-2012-0320 PMID:23403728

- Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. de Jong J, Stoop H, Gillis AJ, van Gurp RJ, van de Geijn GJ, Boer M, Hersmus R, Saunders PT, Anderson RA, Oosterhuis JW, Looijenga LH. J Pathol. 2008 May;215(1):21-30. PMID: 18348160